Keeping you up to date on recent developments in neurology, including: DBS shows promise in treating OCD patients with comorbidities; COVID-19-associated seizures linked to higher risk of death; Antibodies could make things worse in neurodegeneration; Ultrarare variants give insights into schizophrenia.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Nano-X Imaging, Quidel.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chembio Diagnostics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Jemincare, Kite, Moderna, Ose, Regeneron, Tetra.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Claritas, Fusion, GSK, Ipsen, Moderna, Nkmax, Sinovac, Ximedica.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Emergent, Kadmon.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Becton Dickinson, Bluestar Genomics, Inspire.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditx Therapeutics, Collection Sites, Concert Genetics, Corvida Medical, Dalrada, Dedalus, Dx Medical Solutions, Dxc Technology, Egenesis, Euroimmun, Fresenius Kabi, Genematters, Guardant Health, Health Clinics, Invitae, Lifestance Health, Medivolve, Meridian Bioscience, Myomo, Ontrak, Pear Therapeutics, Perkinelmer, Premier, Prescryptive Health, Sqi Diagnostics, Stagezero Life Sciences.

Keeping you up to date on recent developments in diagnostics, including: Blood-based test may help detect early Alzheimer’s disease; AI-based tool helps predict course of COVID-19; Myeloid cells differ in primary and recurrent glioblastoma.